Valuation (36%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 30.06 | 24.13 |
PEG Ratio (TTM) | 35.07 | -0.10 |
P/S Ratio (TTM) | 2.07 | 3.38 |
P/B Ratio (TTM) | 4.13 | 4.36 |
P/FCF Ratio (TTM) | 39.65 | 43.74 |
Price to 5YR AVG Earnings Ratio | N/A | 78.52 |
Price to 5YR AVG FCF Ratio | N/A | 39.96 |
Profitability (35%) |
Company | Industry |
---|---|---|
ROA (TTM) | 6.90% | 7.03% |
ROE (TTM) | 15.22% | 14.43% |
Net Profit Margin (TTM) | 6.89% | 13.50% |
ROIC 5YR AVG | N/A | 14.31% |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -14.65% | 31.60% | N/A |
Revenue | 23.02% | 9.24% | N/A |
Net Income | -15.58% | 31.69% | N/A |
Cash Flow | 113.81% | 18.09% | N/A |
Health (63%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.72 | 2.38 |
Quick Ratio (TTM) | 1.91 | 1.66 |
D/E Ratio (TTM) | 0.47 | 0.51 |
Interest Coverage (TTM) | 5.53 | 9.91 |
Piotroski F-Score | 6 | 8 |
Altman Z-Score | 4.59 | 4.86 |
LTL to 5YR AVG FCF | N/A | 5.64 |
Shares Outstanding Growth 5YR AVG | N/A | -0.91% |